Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients

BackgroundCurrent fertility preservation strategies for young breast cancer patients planning a future motherhood include the association of controlled ovarian stimulation with the aromatase inhibitor letrozole (let-COS) to harvest mature oocytes while maintaining low estradiol levels. Despite this...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Françoise Rothé, Matteo Lambertini, Oranite Goldrat, Marion Maetens, Yacine Bareche, Jeremy Blanc, Ghizlane Rouas, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Isabelle Demeestere
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Subjects:	breast cancer fertility preservation letrozole ovarian stimulation circulating tumor DNA
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.686625/full